-
Photovoltaic 24
-
Wind energy 6
-
Other renewable energy (nuclear, geothermal, etc.) 22
-
Grid/power transmission 23
-
Energy storage 31
-
Hydrogen energy 10
-
Lithium batteries 48
-
Electric vehicles 45
-
Low-carbon buildings and construction 7
-
Agriculture 11
-
Low-carbon consumer goods 6
-
New materials 22
-
Industrial manufacturing 7
-
Green transportation 22
-
CCUS 2
-
Digital technology for carbon accounting and consulting 22
-
Bio-Tech 2
-
Circular economy 31
All investors
114 institutional investors
Content Filter
-
Photovoltaic 24
-
Wind energy 6
-
Other renewable energy (nuclear, geothermal, etc.) 22
-
Grid/power transmission 23
-
Energy storage 31
-
Hydrogen energy 10
-
Lithium batteries 48
-
Electric vehicles 45
-
Low-carbon buildings and construction 7
-
Agriculture 11
-
Low-carbon consumer goods 6
-
New materials 22
-
Industrial manufacturing 7
-
Green transportation 22
-
CCUS 2
-
Digital technology for carbon accounting and consulting 22
-
Bio-Tech 2
-
Circular economy 31
-
Hankang Capital
- Investments: 75
- Funds: 13
- Shanghai
-
Photovoltaic
-
Grid/power transmission
-
Digital technology for carbon accounting and consulting
Hankang Capital (formerly "Shanghai Jianxin Capital") is a venture capital focusing on the biomedical industry. We pay attention to major diseases and major clinical needs, carry out in-depth research, support pioneering companies with first-class team and technology platform in advance, and provide professional insights, experience and resources in product pipeline, team building, application and registration, clinical trials, etc. to promote them to become leading enterprises in the industry as soon as possible. We have invested in Innocare Pharma Limited, Akeso, Chip Screen, Keymed Biosciences, AbbiskoTherapeutics and other industry leading companies. Hankang Capital has won the honors such as "TOP 100 Venture Capital Institutions", "TOP 20 Healthcare Investment Institutions", and "TOP 50 Venture Capital Institutions Recognized by LP in China" for many times.
-
Vinno Capital
- Investments: 59
- Funds: 9
- Shenzhen, Guangdong Province
-
Lithium batteries
-
Circular economy
Vinno Capital, initiated by an investment management team with a global vision and experienced industry background, is an early stage venture capital institution focusing on ICT and medical device-related fields. Vinno Capital will search for cutting-edge technologies in China, North America, and Israel, and mainly invest in technologicial innovation enterprises. With rich industrial experience and successful entrepreneurial experience, we have invested in more than 90 outstanding enterprises with innovative genes, and incubated a number of leading enterprises in various industry segments. Our major investment fields include information technology such as artificial intelligence, communication technology, automotive electronics and medical health, such as in vitro diagnosis, imaging diagnosis, precision medicine, mobile medicine, etc.
-
Empower Investment
- Investments: 247
- Funds: 10
- Shanghai
-
Lithium batteries
-
Electric vehicles
-
Other renewable energy (nuclear, geothermal, etc.)
Empower Investment, established in 2012, headquartered in Shanghai, has set up branches or offices in Beijing, Shenzhen, Hangzhou and Chengdu. The investment team manages a number of RMB and US dollar funds, and its investment business covers early venture capital, medium-term growth investment and securities investment. Up to now, we have invested in more than 200 high-tech and high-growth enterprises in China, the United States, India, South Korea, Hong Kong, Vietnam and other places, covering many fast-growing emerging fields such as internet, artificial intelligence, automation, financial technology, cultural creativity, consumption upgrading, new materials and biomedicine. Empower Investment has invested in more than 100 enterprises, including Hengyuan Electric Vehicles, Linkplay, Ink Weather, Westwell Technology, Juma Logistics, Whalehouse, Cowa Robot, Cobot and so on.
-
CTC Capital
- Investments: 45
- Funds: 7
- Suzhou , Jiangsu Province
-
Electric vehicles
-
Digital technology for carbon accounting and consulting
Founded in 2006, CTC Capital was formed by a team from the largest semiconductor investment firm in Asia Pacific. After more than 20 years’ dedication, the team has made over 180 investment deals in the semiconductor field, with US $billions of total market value, half of which have been successfully listed or sold. In addition to investments in TSMC, UMC, MediaTek, Novatek, KYEC, Hejian, CSMC (CRC Shanghua Technology), AOS, Spreadtrum, Pixart and dozens of other well-known semiconductor companies throughout the industry, we have also created outstanding investment performance in related technology industries. CTC Capital has managed NT dollar funds, US dollar funds and RMB funds. Nanjing Guotiao Guoxin Zhixin Equity Investment Partnership, a subsidiary of CTC Capital, an integrated circuit industry investment fund with an amount 3.5 billion yuan in the first phase, mainly invests in high-end chips, advanced sensors and system modules in artificial intelligence, Internet of Things and industrial 4.0 pan-intelligent equipment, and lays out around the industrial chain. CTC Capital is committed to becoming the most valuable partner of the invested companies and the most trustworthy professional institution in the field of semiconductor investment.
-
MSA Capital
- Investments: 134
- Funds: 4
- Tianjin
-
Other renewable energy (nuclear, geothermal, etc.)
MSA is an independent and interdisciplinary investment firm that actively partners with outstanding entrepreneurs in China and other global technology markets to build leading businesses that positively impact the way we work and live. MSA actively manages more than $1.7 billion in venture capital growth capital from private and public companies. MSA's investment areas include healthy future, corporate productivity and new consumption. Invested enterprises include Meituan, NIO, Boss Zhipin, Yidu Cloud, Biren Tech, Zhiyun Health, etc.